Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo

A phase 4 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 150 participants.

Also called NCT05949008

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose prevention
Phase
Phase 4
Enrolled
  • 150 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT05949008
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT05949008. Randomized; double masking; primary purpose prevention. Start 2023-11-22 (actual); primary completion 2027-10-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Effect of Metformin, a Drug Used to Treat Diabetes, vs Placebo
Condition
NIDDM
Condition
Obesity
Intervention (Drug)
Metformin Extended Release (ER) Oral Tablet
Intervention (Drug)
Placebo
Lead sponsor
University of California, Los Angeles (class: other)

Record details

Record id
cardio:ct-nct05949008
Content hash
cebf4fc568000026d247241f912aa643f8e2823c1a8fb67a730924faf8d3eeb0